Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.6K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

580
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
580
Hazard Rate01:11

Hazard Rate

522
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
522
Hazard Ratio01:12

Hazard Ratio

740
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
740
Odds Ratio01:09

Odds Ratio

2.4K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.4K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

214
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dental disease among adults with and without HIV in the MACS/WIHS Combined Cohort Study (MWCCS).

BMC oral health·2026
Same author

HIV, nephrotoxic medications, and chronic kidney disease: Prevalence, risk factors, and mediation analyses among people with and without HIV enrolled in the Multicenter AIDS Cohort Study (MACS)/ Women's Interagency HIV Study (WIHS) combined cohort study.

PloS one·2026
Same author

Uptake of HIV Self-testing Among Adolescents and Young Adults in Nigeria: A Secondary Observational Analysis of a Stepped-Wedge, Cluster-Randomized Trial.

AIDS and behavior·2026
Same author

List randomization for prevalence estimation of sensitive behavioral data among women with HIV of reproductive age in Lilongwe, Malawi.

American journal of epidemiology·2026
Same author

Syphilis Infections Among Women of Reproductive Age in the Southern United States: An Analysis From the Study of Treatment and Reproductive Outcomes (STAR).

Open forum infectious diseases·2026
Same author

Challenges in malaria diagnosis and treatment in Kinshasa Province, Democratic Republic of the Congo.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Related Experiment Video

Updated: Apr 17, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Risk.

Stephen R Cole, Michael G Hudgens, M Alan Brookhart

    American Journal of Epidemiology
    |February 10, 2015
    PubMed
    Summary

    This study defines risk as a foundational parameter for epidemiologists analyzing health and disease transitions. It introduces methods to quantify risk in complex scenarios with competing events and multiple exposures.

    Area of Science:

    • Epidemiology
    • Biostatistics

    Background:

    • Epidemiologists study health and disease transitions.
    • Quantifying risk is crucial for understanding disease progression and treatment efficacy.

    Purpose of the Study:

    • To define a foundational parameter for epidemiological studies: risk.
    • To extend the definition of risk to scenarios with competing events and multiple treatment levels.

    Main Methods:

    • Develop a conceptual framework for risk in the presence of competing events.
    • Define risks as counterfactual cumulative incidence functions for each treatment.
    • Illustrate with a human immunodeficiency virus (HIV) study example.

    Main Results:

    • Risk is defined as a set of counterfactual cumulative incidence functions in the presence of competing events.
    Keywords:
    causal inferencecohort studysemi-Bayes methodsemiparametric inferencesurvival analysis

    More Related Videos

    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
    13:04

    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

    Published on: September 19, 2012

    12.5K

    Related Experiment Videos

    Last Updated: Apr 17, 2026

    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.8K
    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
    13:04

    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

    Published on: September 19, 2012

    12.5K
  • These risks can be visually depicted and numerically summarized.
  • The framework accommodates multiple event types and exposure levels.

    • Conclusions:

    • The proposed definition of risk provides a robust parameter for epidemiological studies.
    • This approach enhances the analysis of health and disease transitions, especially with competing risks.
    • The methods are applicable to various public health research areas, including infectious disease epidemiology.